These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37307133)

  • 21. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
    Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
    J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.
    Anderson GG; Kenney TF; Macleod DL; Henig NR; O'Toole GA
    Pathog Dis; 2013 Feb; 67(1):39-45. PubMed ID: 23620118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients.
    Feizi S; Cooksley CM; Nepal R; Psaltis AJ; Wormald PJ; Vreugde S
    Pathology; 2022 Jun; 54(4):453-459. PubMed ID: 34844745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes.
    Tarquinio K; Confreda K; Shurko J; LaPlante K
    Antimicrob Agents Chemother; 2014; 58(3):1723-9. PubMed ID: 24379207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
    Chen X; Thomsen TR; Winkler H; Xu Y
    BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
    J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
    Tré-Hardy M; Nagant C; El Manssouri N; Vanderbist F; Traore H; Vaneechoutte M; Dehaye JP
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4409-15. PubMed ID: 20696878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptomycin mediated biofilm inhibition and suppression of virulence properties in Pseudomonas aeruginosa PAO1.
    Khan F; Lee JW; Pham DTN; Lee JH; Kim HW; Kim YK; Kim YM
    Appl Microbiol Biotechnol; 2020 Jan; 104(2):799-816. PubMed ID: 31820066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
    Habash MB; Goodyear MC; Park AJ; Surette MD; Vis EC; Harris RJ; Khursigara CM
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Pseudomonas aeruginosa PQS quorum-sensing system inhibitor with anti-staphylococcal activity sensitizes polymicrobial biofilms to tobramycin.
    Murray EJ; Dubern JF; Chan WC; Chhabra SR; Williams P
    Cell Chem Biol; 2022 Jul; 29(7):1187-1199.e6. PubMed ID: 35259345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y; Yu XH; Wang R; An MM; Liang BB
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitory effect of micafungin on biofilm formation by Pseudomonas aeruginosa.
    Bazzi W; Sabra A; Zahreddine L; Khairallah MT; Baroud M; Hadi U; Matar GM
    Biofouling; 2013 Sep; 29(8):909-15. PubMed ID: 23879871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sound waves effectively assist tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro.
    Bandara HM; Harb A; Kolacny D; Martins P; Smyth HD
    AAPS PharmSciTech; 2014 Dec; 15(6):1644-54. PubMed ID: 25155975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
    Moreau-Marquis S; Coutermarsh B; Stanton BA
    J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections.
    Ham SY; Kim HS; Jo MJ; Lee JH; Byun Y; Ko GJ; Park HD
    Microbiol Spectr; 2021 Oct; 9(2):e0019221. PubMed ID: 34704784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manuka honey treatment of biofilms of Pseudomonas aeruginosa results in the emergence of isolates with increased honey resistance.
    Camplin AL; Maddocks SE
    Ann Clin Microbiol Antimicrob; 2014 May; 13():19. PubMed ID: 24884949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Pseudomonas aeruginosa activity of 1,10-phenanthroline-based drugs against both planktonic- and biofilm-growing cells.
    Viganor L; Galdino AC; Nunes AP; Santos KR; Branquinha MH; Devereux M; Kellett A; McCann M; Santos AL
    J Antimicrob Chemother; 2016 Jan; 71(1):128-34. PubMed ID: 26416778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.